Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection.
Shen, Y., Zhukovskaya, N.L., Zimmer, M.I., Soelaiman, S., Bergson, P., Wang, C.R., Gibbs, C.S., Tang, W.J.(2004) Proc Natl Acad Sci U S A 101: 3242-3247
- PubMed: 14978283 
- DOI: 10.1073/pnas.0306552101
- Primary Citation of Related Structures:  
1PK0 - PubMed Abstract: 
Edema factor (EF), a key virulence factor in anthrax pathogenesis, has calmodulin (CaM)-activated adenylyl cyclase activity. We have found that adefovir dipivoxil, a drug approved to treat chronic infection of hepatitis B virus, effectively inhibits EF-i ...